相关实验视频

Updated: May 8, 2025

Purifying the Impure: Sequencing Metagenomes and Metatranscriptomes from Complex Animal-associated Samples

Purifying the Impure: Sequencing Metagenomes and Metatranscriptomes from Complex Animal-associated Samples

Published on: December 22, 2014

在后急性COVID-19综合征 (PACS) 中的人类微生物组

Arezoo Fallah¹, Hamid Sedighian², Reza Kachuei³

¹Department of Bacteriology and Virology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Current research in microbial sciences

|December 24, 2024

概括

随着COVID-19大流行的持续,SARS-CoV-2正在影响肠道微生物群. 本综述探讨了肠道细菌及其代谢物如何用于新型COVID-19和后急性COVID-19综合征 (PACS) 治疗.

科学领域:

微生物学微生物学
免疫学免疫学免疫学
传染性疾病传染性疾病

背景情况:

由SARS-CoV-2引起的COVID-19大流行,呈现出胃肠道症状,并准表达ACE2和TMPRSS2.2的呼吸道和胃肠道.
在COVID-19和后急性COVID-19综合征 (PACS) 患者中观察到肠道微生物组的变化.
微生物组在各种疾病,包括病毒感染中起着至关重要的免疫调节作用.

研究的目的:

研究COVID-19中宿主微生物群相互作用的治疗潜力.
探索微生物群衍生成分影响对SARS-CoV-2免疫反应的机制.
讨论管理COVID-19和PACS的基于微生物群的战略.

主要方法:

关于COVID-19,SARS-CoV-2和人类微生物组研究的文献综述.
对将微生物群代谢物与宿主免疫和病毒感染联系起来的机制的分析.
检查微生物组研究中的混因素.

主要成果:

微生物群衍生代谢物和成分是宿主微生物相互作用的关键媒介,影响免疫力.
讨论了微生物产品影响宿主对SARS-CoV-2免疫反应的特定机制.
在微生物组研究中确定和解决混因素.

结论:

肠道微生物组为治疗COVID-19和PACS的治疗干预提供了一个有希望的目标.
基于微生物群的预防措施和治疗可能会影响临床结果和疾病严重程度.
对微生物群与宿主相互作用的进一步研究对于开发有效策略至关重要.

关键词:

在 COVID-19 疫情中,微生物组是一个微生物组.微生物群中的微生物群 PACS PACS 是一个小组.后急性COVID-19综合征是什么

更多相关视频

Assessing the Viability of a Synthetic Bacterial Consortium on the In Vitro Gut Host-microbe Interface

Assessing the Viability of a Synthetic Bacterial Consortium on the In Vitro Gut Host-microbe Interface

Published on: July 4, 2018

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

相关概念视频

What is Monogastric Digestion?

What is Monogastric Digestion?

The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Factors Affecting the Risk of Infection

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...